230 related articles for article (PubMed ID: 30486313)
21. Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA.
Woerner AC; Frottin F; Hornburg D; Feng LR; Meissner F; Patra M; Tatzelt J; Mann M; Winklhofer KF; Hartl FU; Hipp MS
Science; 2016 Jan; 351(6269):173-6. PubMed ID: 26634439
[TBL] [Abstract][Full Text] [Related]
22. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R; Neumann M
Lancet Neurol; 2010 Oct; 9(10):995-1007. PubMed ID: 20864052
[TBL] [Abstract][Full Text] [Related]
23. TAR DNA binding protein-43 and fused in sarcoma/translocated in liposarcoma protein in two neurodegenerative diseases.
Wang XN; Cui LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):286-92. PubMed ID: 22776664
[TBL] [Abstract][Full Text] [Related]
24. TDP-43 and FUS: a nuclear affair.
Dormann D; Haass C
Trends Neurosci; 2011 Jul; 34(7):339-48. PubMed ID: 21700347
[TBL] [Abstract][Full Text] [Related]
25. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
Neumann M
Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
[TBL] [Abstract][Full Text] [Related]
26. Unconventional Secretion and Intercellular Transfer of Mutant Huntingtin.
Tang BL
Cells; 2018 Jun; 7(6):. PubMed ID: 29904030
[TBL] [Abstract][Full Text] [Related]
27. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
Baloh RH
Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
[TBL] [Abstract][Full Text] [Related]
28. Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma.
Bentmann E; Haass C; Dormann D
FEBS J; 2013 Sep; 280(18):4348-70. PubMed ID: 23587065
[TBL] [Abstract][Full Text] [Related]
29. Regulating Phase Transition in Neurodegenerative Diseases by Nuclear Import Receptors.
Girdhar A; Guo L
Biology (Basel); 2022 Jul; 11(7):. PubMed ID: 36101390
[TBL] [Abstract][Full Text] [Related]
30. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
Lu B; Palacino J
FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
[TBL] [Abstract][Full Text] [Related]
31. Engineering enhanced protein disaggregases for neurodegenerative disease.
Jackrel ME; Shorter J
Prion; 2015; 9(2):90-109. PubMed ID: 25738979
[TBL] [Abstract][Full Text] [Related]
32. Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions.
Davranche A; Aviolat H; Zeder-Lutz G; Busso D; Altschuh D; Trottier Y; Klein FA
Hum Mol Genet; 2011 Jul; 20(14):2795-806. PubMed ID: 21518730
[TBL] [Abstract][Full Text] [Related]
33. A Quantitative Heterokaryon Assay to Measure the Nucleocytoplasmic Shuttling of Proteins.
McNicoll F; Müller-McNicoll M
Bio Protoc; 2018 Sep; 8(17):e2472. PubMed ID: 34395784
[TBL] [Abstract][Full Text] [Related]
34. Mislocalization of Nucleocytoplasmic Transport Proteins in Human Huntington's Disease PSC-Derived Striatal Neurons.
Lange J; Wood-Kaczmar A; Ali A; Farag S; Ghosh R; Parker J; Casey C; Uno Y; Kunugi A; Ferretti P; Andre R; Tabrizi SJ
Front Cell Neurosci; 2021; 15():742763. PubMed ID: 34658796
[TBL] [Abstract][Full Text] [Related]
35. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.
Lee WC; Yoshihara M; Littleton JT
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3224-9. PubMed ID: 14978262
[TBL] [Abstract][Full Text] [Related]
36. Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure.
Ding X; Ma M; Teng J; Teng RK; Zhou S; Yin J; Fonkem E; Huang JH; Wu E; Wang X
Oncotarget; 2015 Sep; 6(27):24178-91. PubMed ID: 26172304
[TBL] [Abstract][Full Text] [Related]
37. Neuronal RNA-binding protein dysfunction in multiple sclerosis cortex.
Salapa HE; Hutchinson C; Popescu BF; Levin MC
Ann Clin Transl Neurol; 2020 Jul; 7(7):1214-1224. PubMed ID: 32608162
[TBL] [Abstract][Full Text] [Related]
38. Autophagy and apoptosis dysfunction in neurodegenerative disorders.
Ghavami S; Shojaei S; Yeganeh B; Ande SR; Jangamreddy JR; Mehrpour M; Christoffersson J; Chaabane W; Moghadam AR; Kashani HH; Hashemi M; Owji AA; Łos MJ
Prog Neurobiol; 2014 Jan; 112():24-49. PubMed ID: 24211851
[TBL] [Abstract][Full Text] [Related]
39. RNA-binding protein altered expression and mislocalization in MS.
Masaki K; Sonobe Y; Ghadge G; Pytel P; Lépine P; Pernin F; Cui QL; Antel JP; Zandee S; Prat A; Roos RP
Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32217641
[TBL] [Abstract][Full Text] [Related]
40. Karyopherin abnormalities in neurodegenerative proteinopathies.
Pasha T; Zatorska A; Sharipov D; Rogelj B; Hortobágyi T; Hirth F
Brain; 2021 Nov; 144(10):2915-2932. PubMed ID: 34019093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
